Hixon Zuercher LLC Sells 3,272 Shares of NVIDIA Co. (NASDAQ:NVDA)
Hixon Zuercher LLC cut its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 5.8% during the 4th quarter, according to its ...
manilatimes2 小时
Phoenix Group to Attend Cantor Fitzgerald Global Technology Conference In New York, USA
Phoenix Group PLC (ADX:PHX), a global leader in Bitcoin mining, blockchain, and next-generation digital and AI infrastructure, is excited to announce that its CEO and Co-Founder, Munaf Ali, will lead ...
Mizuho Downgrades Intra-Cellular Therapies (NASDAQ:ITCI) to Neutral
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was downgraded by research analysts at Mizuho from an “outperform” ...
UAE-Based Phoenix Group to Attend Cantor Fitzgerald Global Technology Conference in New York
The conference brings together industry experts, investors, and innovators to discuss the latest trends and opportunities in technology.
Lucid CEO to step down, company expects vehicle production to more than double this year
By Zaheer Kachwala (Reuters) -Electric-vehicle maker Lucid Group said on Tuesday its Chief Executive Officer Peter Rawlinson ...
Why Artificial Intelligence Stocks SoundHound AI, IonQ, and C3.ai Are Struggling Today
Shares of several technology and artificial intelligence (AI) stocks struggled today, due to reports of further export ...
Bingo lenders shop debt after S&P downgrade
Sharp-nosed credit funds in Sydney have fielded approaches from New York’s Cantor Fitzgerald, which is said to be shopping a ...
Cantor Fitzgerald维持SI-BONE股票增持评级，目标价USD 25
周二，Cantor Fitzgerald重申对SI-BONE Inc.（NASDAQ: SIBN）的增持评级，维持USD 25.00的目标价。这一评级确认是在SI-BONE公布2024年第四季度业绩并提供2025年财务指引后作出的。SI-BONE 2024年第四季度营收为USD 49.0 million，超过了Cantor Fitzgerald预期的USD 46.8 ...
Cantor Fitzgerald上调Ascendis Pharma目标价至200美元，维持增持评级
周二，Cantor Fitzgerald分析师调整了对Ascendis Pharma（NASDAQ:ASND）股票的估值，将目标价从此前的170美元上调至200美元，同时维持增持评级。此次调整是在Ascendis Pharma发布2024年第四季度财报后做出的，该公司业绩表现超出预期。根据 InvestingPro ...